CVE-2023-46729

Sentry Next.js vulnerable to SSRF via Next.js SDK tunnel endpoint

Description

sentry-javascript provides Sentry SDKs for JavaScript. An unsanitized input of Next.js SDK tunnel endpoint allows sending HTTP requests to arbitrary URLs and reflecting the response back to the user. This issue only affects users who have Next.js SDK tunneling feature enabled. The problem has been fixed in version 7.77.0.

Category

9.3
CVSS
Severity: Critical
CVSS 3.1 •
EPSS 1.09% Top 25%
Vendor Advisory github.com
Affected: getsentry sentry-javascript
Published at:
Updated at:

References

Link Tags
https://github.com/getsentry/sentry-javascript/security/advisories/GHSA-2rmr-xw8m-22q9 vendor advisory
https://github.com/getsentry/sentry-javascript/pull/9415 patch
https://github.com/getsentry/sentry-javascript/commit/ddbda3c02c35aba8c5235e0cf07fc5bf656f81be patch

Frequently Asked Questions

What is the severity of CVE-2023-46729?
CVE-2023-46729 has been scored as a critical severity vulnerability.
How to fix CVE-2023-46729?
To fix CVE-2023-46729, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-46729 being actively exploited in the wild?
It is possible that CVE-2023-46729 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-46729?
CVE-2023-46729 affects getsentry sentry-javascript.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.